Hutch News

COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days

COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days

From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
Science SpotlightMarch 21, 2025
COVID-19 complacency: ‘A hard shift for the immunocompromised’

COVID-19 complacency: ‘A hard shift for the immunocompromised’

Even with vaccines and antivirals, cancer patients and many others are still vulnerable to infection; some safety tips for this evolving pandemic
Hutch NewsAugust 25, 2022
Cancer, COVID-19 and proceeding with caution

Cancer, COVID-19 and proceeding with caution

Patients in treatment and those with compromised or suppressed immune systems eye the future — and pandemic’s wane — warily
Hutch NewsFebruary 16, 2022
Catching up with cancer as COVID-19 starts to ebb

Catching up with cancer as COVID-19 starts to ebb

Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
Hutch NewsJune 29, 2021
'Everything we’ve been training for is happening now'

'Everything we’ve been training for is happening now'

How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Hutch NewsSeptember 16, 2020
What happens if the coronavirus’s spikes mutate?

What happens if the coronavirus’s spikes mutate?

First-of-its-kind study explores how changes in the virus’s ‘lock picks’ could help or hinder its ability to sneak into our cells
Hutch NewsAugust 13, 2020